Format

Send to

Choose Destination
Ann Intern Med. 2004 Dec 7;141(11):835-8.

Management of implantable cardioverter defibrillators in end-of-life care.

Author information

1
Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut, USA. nathan.goldstein@mssm.edu

Abstract

BACKGROUND:

Implantable cardioverter defibrillators (ICDs) can prevent premature death from an arrhythmia but may also prolong the dying process and make it more distressing.

OBJECTIVE:

To describe the frequency, timing, and correlates of discussions about deactivating ICDs.

DESIGN:

Retrospective cohort study.

SETTING:

Telephone survey.

PARTICIPANTS:

Next of kin of patients with ICDs who died of any cause. Of 136 next of kin contacted, 100 (74%) participated.

MEASUREMENTS:

Incidence of discussions about deactivating ICDs and timing of last shock from ICD.

RESULTS:

Next of kin reported that clinicians discussed deactivating the ICD in only 27 of the 100 cases. Most discussions occurred in the last few days of life. Family members reported that 8 patients received a shock from their ICD in the minutes before death.

LIMITATIONS:

This retrospective survey relied on the reports of next of kin.

CONCLUSIONS:

Next of kin reported that clinicians discussed deactivating ICDs with few patients. Individuals who choose to receive this device should have the opportunity to choose to discontinue it as death approaches.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center